As a recent hire, you’d like to become familiar with the current organizational structure in Johnson and Johnson. This org chart has not yet been created, so you decide to make your own. Use the templ

SUPERIOR-PAPERS.COM essay writing company is the ideal place for homework help. If you are looking for affordable, custom-written, high-quality and non-plagiarized papers, your student life just became easier with us. Click the button below to place your order.

Order a Similar Paper Order a Different Paper

As a recent hire, you’d like to become familiar with the current organizational structure in Johnson and Johnson. This org chart has not yet been created, so you decide to make your own. Use the templates attached for the basis of your information.

Part 1:

Create an organizational chart (org chart) of your company based on the initiatives discussed in the templates. This high-level information is typically found on the company’s website or other websites about the organization. The org chart should include key leadership and level of responsibility. If the information is not public, base your decisions on a similar organization and research. You may use any Microsoft program or web-based program.

Part 2:

Explain in 350- words the structure of your org chart. Discuss the type of hierarchy and related details of each role. Assess how each role in the organizational chart is related to the other areas within the organization.

Format your citations according to APA guidelines

As a recent hire, you’d like to become familiar with the current organizational structure in Johnson and Johnson. This org chart has not yet been created, so you decide to make your own. Use the templ
Organizational Analysis Define your chosen company and its industry. Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. Mission and Vision Identify the mission and vision of the organization. Mission Bring the science and sense of sight to life through world-class innovation and patient experiences. Vision We help people see better, connect better and live better. Organizational Initiatives Outline 1-2 major initiative for this organization. What are they currently doing to support these initiatives? To improve the vaccine production and research. How, by offering great value to the customers through the store and Internet research experience. The Johnson & Johnson Family of Companies is organized into three business segments— Consumer, Pharmaceuticals, and Medical Devices. It the world’s most broadly based global health care business serving customers, patients and medical professionals through more than 275 companies in over 60 countries. Organizational Plans Describe the plans employed by the organization. Determine which types of managers create each type of plan. Type of Plan Description Type of Manager joint partnership plan To open 10 additional research centers in high-traffic research company and drug supply Top-level managers overseas research plan Provided the company with a platform for developing and the success of other products. Top or corporate managers SWOT Analysis There are various factors within the external environment of an organization that impacts its strategy. Analyze the organization’s SWOT analysis. Identify the internal and external factors. Include a link to the SWOT analysis in the Reference section of this worksheet. Internal Factors Strength: Multiple channels selling Wide geographic presence High liquidity position Weakness: uneven Revenue Distribution, fall in Consumer Health Sales, unethical Practices: External Factors Opportunity: Customer loyalty programs Strategic partnership Growing e- Commerce sales across the globe, Robotic Surgical System, Mergers and Acquisitions, Tele-Health. Threat: Rising labor costs in the US Intensified competition Foreign exchange risks, government Regulations, corporate Espionage. Part 2: Evaluation Evaluate if the mission, vision, planning process, and SWOT analysis meets the current needs of the organization. Include the following in your evaluation: Describe the unmet need, (not limited to product or service, can be new demographic, new mode of delivery, etc.). Analyze your competitive advantages. Based upon the SWOT analysis, is there another business that is doing something similar that can be referred to? Provide examples. If there is not another business, describe how what you’re doing is a unique product or service offering. Propose a competitive business initiative to address the unmet need. Create a high-level timeline and operational steps necessary to implement your solution. Answer and Explanation This SWOT analysis shows that Johnson & Johnson’s revenue stream and global reach are its most important assets. When you examine Johnson & Johnson’s flaws, you’ll discover that the company relies too heavily on a small number of high-margin products. In addition, Johnson & Johnson’s resources are being strained by the costs of lawsuit settlements. Weaknesses like these must be overcome for Johnson & Johnson to move forward. If Johnson & Johnson’s one-dose vaccination passes clinical trials, it will be a game-changer. In conclusion, a pharmaceutical behemoth, Johnson & Johnson, has been summoned to assist the world in its hour of need. Johnson & Johnson has a long history of philanthropy, and it stands to benefit both its reputation and bottom line by responding to the call to service. Reference Pharmaphorum. (2021). A history of Johnson & Johnson. Retrieved January 23, 2022, from Reed, E. (2020). History of Johnson & Johnson: Timeline and Facts. Retrieved January 23, 2022, from Brief History of Company Three brothers formed Johnson & Johnson in 1886. They include Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson. The inspiration to form the company was based on Lister’s antiseptic methods. The newly founded entity focused on developing methods for sterilization and surgical dressings, hoping to develop an efficient sterilization approach (Reed, 2020). In 1887, the company was officially incorporated as Johnson & Johnson and in the following year produced ready-made first aid kits and published a guide for treating injuries. The first-aid kit was an instant success, especially among industrial workers and general consumers. Afterward, the company would release maternity kits and baby powder products. The aim was to expand the product line to include baby and maternity products. The maternity kits were intended to make childbirth safer, while the baby powder was a success and is still for sale today (Reed, 2020). Johnson & Johnson consistently built the reputation of developing healthcare and sanitation products. In the 1930s through to the 50s, the company developed its modern corporate structure. At the time, CEO Robert Wood Johnson II decentralized the company into smaller units that all report to the Johnson & Johnson corporation. The rationale was that each unit would specialize. The real distinguishing factor in Johnson & Johnson came when the company started to purchase pharmaceutical research companies. The first two are Cilag Chemie AG and McNeil Laboratories. Afterward, Jansenn Pharmaceutica was added under the umbrella leading to the creation of the company’s pharmaceuticals and research division (Pharmaphorum, 2021). These acquisitions enabled the company to develop its drug product lines. The company has steadily developed in research and development, leading to innovations such as drug treatments for schizophrenia and the first coronary stent (Reed, 2020). Milestones from The Company’s History Johnson & Johnson’s first milestone was the creation of commercial first aid kits. The kits improved the condition of railroad workers and workers from other industries. The first-aid kit was an instant success and has become the standard for treating injuries on the scene (Pharmaphorum, 2021). It is a significant contribution and innovation in healthcare that still offers benefits in the 21st century. The invention also propelled the brand name of Johnson & Johnson. It provided the company with a platform for developing and the success of other products such as maternity kits and the baby powder label. The second milestone for Johnson & Johnson is the incorporation of Janssen into the corporation. Janssen provided the company with innovation and vital pharmaceutical research. Janssen’s profile remains high, and the company is still one of the world’s leading companies in pharma research. Within Johnson & Johnson, Janssen is split into Research & Development, Janssen Diagnostics, and Janssen Healthcare Innovation. Janssen has developed successful drugs, including Reminyl for Alzheimer’s and Immodium, a diarrhea treatment. The third Johnson & Johnson milestone is the development of its COVID-19 vaccine. The pandemic’s start in 2020 found the company established and with adequate resources to begin research on a vaccine. Unlike the double dose vaccine from most of its competitors, Johnson & Johnson’s vaccine is a single dose. The development of the COVID vaccine emphasized the dominant role the company plays in the pharmaceutical industry. Information Sources The first source of information is the Johnson & Johnson website. The website contains relevant information regarding the company’s status, its initiatives, and information regarding products and suppliers. The second information source is the Drug Information Database from The information contained in the database is sourced from independent suppliers of medical information, such as the American Society of Health-System Pharmacists. The website has information regarding drugs produced by Johnson & Johnson and its subsidiaries, such as Janssen. The last source is Statista which contains relevant Johnson & Johnson statistics such as revenue, growth, and sales. Unique Business Opportunity The unique opportunity for Johnson & Johnson is its single-dose COVID vaccine. While vaccines from competitors such as Pfizer and Moderna require two doses, the company has developed a single dose shot, attracting individuals who want to avoid the hassle of seeking two doses. The COVID pandemic is still ongoing, with new variants emerging. Johnson & Johnson should increase vaccine production while researching the new strains. The outcome will increase the company’s competitiveness and appeal. Function of Management Needed for Opportunity The primary managerial support needed for the opportunity is support. An increase in vaccine production and rollout requires efficient planning and organization for efficiency. Moreover, management should ensure the company has adequate financial resources to fund research and support manufacturing efforts. Staffing is also vital; thus, management should ensure they acquire the talent to promote successful outcomes in both research and manufacturing. References Pharmaphorum. (2021). A history of Johnson & Johnson. Retrieved January 23, 2022, from Reed, E. (2020). History of Johnson & Johnson: Timeline and Facts. Retrieved January 23, 2022, from Johnson & Johnson Five Porter’s Analysis Johnson & Johnson is a multinational holding company engaged in the research, development, manufacture and sale of a broad range of products within the healthcare industry. The company operates within three segments of consumers, pharmaceuticals and medical devices (Johnson and Johnson, 2022). The company’s broad operations expose it to varying threats within its market, as well as various levels of competition. A Five Porter’s Analysis of the company give insight into that kind of threats the company faces within the five elements covered by the Five Porter’s Model, and the impact those threats have on its competitiveness within the market. Threat of New Entrants The threat of new entrants is low for Johnson & Johnson. The health industry within which the company operates has several barriers that are restrictive for the entry of new players. Potential entrants into the health industry, particularly in the field of pharmaceuticals and medical devices, are faced with steep starting costs, a need for costly and hard to find skilled labor, expensive and technology, and the need to compete with well-established brands with a reputation such as Johnson & Johnson. The company therefore, faces minimal risk of competition from new entrants. Bargaining Power of Suppliers The bargaining power of suppliers for Johnson & Johnson is high. The health industry has high demands in terms of quality and cost for suppliers which means there are very few, and for a company like Johnson & Johnson which already has a reputation for quality and works with specific suppliers, the number of suppliers is few for such a large company. The low number of suppliers, the unique products they supply, and the standards they must meet means they have a high bargaining power. To overcome such bargaining power, J&J has to further diversify its supply-chain to different locations and companies, and reduce reliance on suppliers for products that can be sourced easier in-house. Bargaining Power of Buyers J&J operates at varying levels with numerous categories of buyers ranging from consumers, wholesalers, retailers, and manufacturers (Johnson and Johnson, 2022). The variety in terms of category, and overall number of buyers means the company does not face stiff competition for a single buyer category, and has numerous customers at any given time which lowers the bargaining power of the company’s buyers and grants it greater leeway to determine prices and maximize its profits. Threat of Substitutes The company produces both specialized products such as the Johnson & Jonhson Covid-19 vaccine, and general products such as first aid kits (Johnson and Johnson, 2022). While the threat of substitutes for specialized, or proprietary products such as its vaccines is low, it does face stiffer competition for more general products such as its baby powder line. The company however, does have a strong reputation that staves off competition from less reputable brands. The company can focus on unique products to reduce the possibility of substitutes. Industry Rivalry The main competitors for J&J within its market comprise multinational companies such as, Unilever, Merck, Bristol Myers Squibb and Pfizer, all of which like J&J serve a variety of segments within the health industry (Comparably, 2022). These multinationals while few, present the stiffest competition for J&J as they operate at the same level, with similar structures, and are themselves well known companies with popular household brands. To stave off competition from these major players the company has undertaken a series of acquisitions such as buying Pfizer Consumer Healthcare in 2006, and Actelion in 2017 (Pharmaphorum, 2021). Johnson & Johnson Leadership Style Analysis Current Leadership Style The current leadership at J&J is a transactional leadership style centered on rewarding or punishing employees based on their performance with those who perform well receiving bonuses and other rewards, while those that do not perform to expectation either left out or facing increasing pressure to bolster their performance. Effectiveness and Alternatives to Current Leadership Style J&J’s transactional leadership style has been effective given the huge strides the company has made in terms of delivering products to its numerous buyers on time, and with the needed quality. As a multinational the company operates in numerous countries and supplies a variety of products, therefore, a transactional leadership style works best in ensuring continued performance. Additionally, this leadership style has ensured the company has stayed in-line with its mission, vision and corporate objectives. However, an alternative leadership style, a transformational leadership style, is one that suites the company better today than transactional leadership. The modern world is ever-changing, information driven, and with a more conscious workforce, and consumer market. The modern world therefore, has a higher demand for innovation, and readiness to adapt to changes as evidenced by the emergence of Covid-19, and the growth of such technologies as AI. Transformational leadership which inspires innovation, and adaptability is therefore the most suitable. Effective Leadership Effective leadership is centered on whether a leader both achieves the goals set out for them, and inspires their followers to buy into, support, and strive to achieve those goals while keeping them motivated, and fulfilled. To measure effective leadership, one must look at whether the leadership supports and meets the mission, vision, and objectives set out, and how it impacts the employees and company as whole, specifically its positive impact. Leadership Changes A shift towards a transformational leadership style, is one that suites the company better today than transactional leadership. The modern world is ever-changing, information driven, and with a more conscious workforce, and consumer market. Therefore, the company needs a leadership style that will facilitate innovation and adaptability. Two actions that the company can take to align its operational needs with its business strategies are to enhance its performance and competitiveness are, reduce internal inefficiencies to enhance effectiveness, reduce waste and maximize resources, and fine-tuning departmental goals, team and employee objectives to align with the organizations business strategy so that all actions at all levels are geared towards meeting those objectives. References Comparably. (2022). Johnson & Johnson Competitors. Retrieved from Comparably: Johnson and Johnson. (2022). About Johnson & Johnson. Retrieved from Johnson & Johnson: Pharmaphorum. (2021, February 26). A history of Johnson & Johnson. Retrieved from Pharmaphorum:,Jersey%20in%20the%20United%20States.&text=Between%201896%20and%201897%2C%20J%26J,mass%2Dproduced%20sanitary%

Got stuck with a writing task? We can help! Use our paper writing service to score better grades and meet your deadlines.

Get 15% discount for your first order

Order a Similar Paper Order a Different Paper